Reducing medication errors before they happen

As medication errors continue to rise, never has it been more critical to have the right drug information when prescribing, dispensing, and adjudicating claims. But while data abounds to help healthcare decision making, healthcare professionals struggle to find a way to seamlessly ensure patient safety while working efficiently.

video screen - why medi-span
Watch Video
Why Medi-Span for drug data?
See the 5 reasons more healthcare professionals choose Medi-Span data for clinical screening and more in this video.
Powerful content and sophisticated technology to help you reduce medication errors

Medi-Span is the leading clinical screening solution, using technology to guide medication-related decisions. It is designed to help healthcare professionals avoid medication errors, inappropriate dosing and adverse events. Medi-Span offers you the flexibility to use expert clinical screening in various aspects of your workflow - from prescribing to dispensing to claims processing.

Helping healthcare decision makers easily screen medications for safety and reduce medication errors

The rise of adverse drug events continues to be a significant issue that impacts patient outcomes, and healthcare professionals are faced with complex medication-related decisions each day. What’s more, a variety of factors about the patient must be considered before making medication decisions, or the consequences can be dire.


We are here to help.

Medi-Span's solution to support clinical screening includes:
  • Adverse Drug Effects
    • Provides data to support identification of a drug’s potential adverse effects
    • Adverse effects are quantified by severity, incidence, and onset
  • Dose Screening and Drug Orders
    • Provides information about a drug’s dose, frequency, and duration of therapy (Dose Screening); dosing at the ingredient level of a drug; and instructions for use — often referred to as sigs, the Latin for “to write” (Drug Orders)  
    • Dose range screening for adult, pediatric, and neonatal patient populations  
    • Patient inputs include patient age, weight, body surface area, renal function, medical condition, and dose type  
    • Multiple types of screening can be performed including daily low/high/max, single dose max, frequency low/high/max, therapy duration low/high/max, and lifetime max
  • Drug Allergy Screening
    • Provides data content about drug allergies and associated adverse reactions
    • Includes drugs and herbal/natural products
    • Facilitates screening by ingredient, allergen class, or drug product
    • Differentiates allergies by type: same drug, same class, or cross-sensitivity
    • Additionally, the API provides “common” concepts for allergens that facilitate creation of a clinician picklist that can be used to populate a patient’s allergy profile
  • Drug Disease Contraindications
    • Assists in the detection and reporting of conflicts related to the use of a medication in a patient with a given disease state or known genetic factors
    • Filter parameter available for Severity Level filtering; parameter ranges from Contraindicated to Informational levels
  • Drug Interaction Screening
    • Provides information about drug-drug, drug-food, and drug-alcohol interactions
    • Provides route- and ingredient-specific interactions and allows for latency interactions
    • Includes attributes for severity and includes level of supporting documentation, management, and onset
  • Drug-Lab Conflicts
    • Identifies undesired effects that drugs may potentially have on lab test results  
    • Provides decision support when interpreting lab results and analyzing results, as required by healthcare regulatory standards  
    • Helps reduce risk by helping to prevent drug-lab conflicts from occurring and supporting appropriate monitoring of patient clinical status  
    • Helps improve quality of patient care through advanced identification of potentially inappropriate lab test results  
    • Aids in reducing expenses related to drug invalidation of lab test results
  • Duplicate Therapy Screening
    • Provides data to support screening for potentially inappropriate therapeutic duplications 
    • Includes codes identifying duplications involving ingredient, mechanism of action, or therapeutic indication, as well as a Duplication Allowance Indicator to specify a number of acceptable duplications before providing an alert
  • Medication Orders / "SIGs"
    Provides data to support clinicians during the medication prescribing process. Includes customizable medication orders, or “sigs,” based on patient parameters such as age weight, renal function, body surface area, and indication
  • Morphine Equivalent Dosing
    Provides healthcare professionals with tools to help calculate morphine equivalent dosing (MED) for a more detailed look at a patient’s opioid intake to help professionals safely prescribe pain medications and balance the risks and benefits
  • Pregnancy, Lactation, Age, and Gender Screening
    • Provides data to support screening for potential therapeutic conflicts between a drug and a patient based on available information about current medical condition, age, gender, pregnancy/lactation status, and known pharmacogenomic factors 
    • The significance of the therapeutic conflict is quantified, allowing users to determine which screening alerts they wish to receive  
  • Route Contraindications

    Identifies routes of administration contraindicated or not recommended due to:

    • Safety concerns (e.g., Vincristine Sulfate via intrathecal route, otic solutions via ophthalmic route)
    • Drug formulation (e.g., extended release oral tablets via nasogastric tube)
Back To Top